Gilead Sciences | GILD - Ebit

Gilead Sciences reported $2.27B in EBIT for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ebit Change
Acorda Therapeutics ACOR:US USD 269K 5.26M
Agios Pharmaceuticals AGIO:US USD -99172000 8.08M
ALKERMES ALKS:US USD -19227000 41.41M
Alnylam Pharmaceuticals ALNY:US USD -188614000 69.43M
Amgen AMGN:US USD 2.23B 436M
Biogen BIIB:US USD 878.7M 6.6M
Biomarin Pharmaceutical BMRN:US USD -24500000 22.08M
Bluebird Bio BLUE:US USD -86480000 14.28M
Bristol Myers Squibb BMY:US USD 2.32B 418M
Coherus Biosciences CHRS:US USD -51493000 28.96M
Eli Lilly And LLY:US USD 2.11B 169.2M
Gilead Sciences GILD:US USD 2.27B 565M
GlaxoSmithKline GSK:LN GBP 1.44B 967M
Glaxosmithkline GSK:US GBP 1.44B 967M
Intercept Pharmaceuticals ICPT:US USD -17985000 7.84M
Johnson & Johnson JNJ:US USD 6.27B 572M
Merk MRK:US USD 4.81B 725M
Moderna Inc MRNA:US USD 1.58B 414M
Neurocrine Biosciences NBIX:US USD 103.4M 15.6M
Novartis NOVN:VX USD 3.1B 228M
Pfizer PFE:US USD 5.81B 3.89B
Ptc Therapeutics PTCT:US USD -166957000 98.77M
Puma Biotechnology PBYI:US USD 10.02M 7.62M
Regeneron Pharmaceuticals REGN:US USD 1.18B 46.9M
Sangamo Biosciences SGMO:US USD -55392000 498K
Sarepta Therapeutics SRPT:US USD -106833000 24.52M
Teva Pharmaceutical Industries TEVA:US USD 999M 259M
United Therapeutics UTHR:US USD 186.8M 127.5M
Vertex Pharmaceuticals VRTX:US USD 1.04B 89.7M
YTE INCY:US USD 93.36M 24.89M